EA200100062A1 - Фталазиновые производные ингибиторов производных фосфодиэстеразы 4 - Google Patents
Фталазиновые производные ингибиторов производных фосфодиэстеразы 4Info
- Publication number
- EA200100062A1 EA200100062A1 EA200100062A EA200100062A EA200100062A1 EA 200100062 A1 EA200100062 A1 EA 200100062A1 EA 200100062 A EA200100062 A EA 200100062A EA 200100062 A EA200100062 A EA 200100062A EA 200100062 A1 EA200100062 A1 EA 200100062A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- alkyl
- aryl
- alkoxy
- heterocycle
- optionally substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/34—Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyridine Compounds (AREA)
Abstract
Соединения формулы (I), в которой === представляет собой простую или двойную связь; Z представляет собой NH, метилен, (C-C)алкиленовую цепь, необязательно разветвленную, и/или ненасыщенную, и/или разорванную (C-C)циклоалкильным остатком; A представляет собой фенил или гетероцикл, необязательно замещенный на один или более заместителей, выбранных из оксо-, нитро-, карбоксигрупп и атомов галогена, или CORгруппу, в которой Rпредставляет собой гидрокси, (C-C)алкокси, амино, необязательно замещенный на одну или две (C-C)алкильные группы или на гидрокси; R представляет собой (C-C)алкил или полифтор(C-C)алкильную группу; Rотсутствует, если === представляет собой двойную связь или если === представляет собой простую связь, то он представляет собой а) водород; б) (C-C)алкил, необязательно замещенный на арил, на гетероцикл или на CORгруппу, в которой Rпредставляет собой гидрокси, (C-C)алкокси или гидроксиамино; в) -COR, где Rпредставляет собой водород, арил, арил-(C-C)алкил, необязательно алкилированный или моногидроксилированный амино, гидрокси, (C-C)алкокси, карбокси, (C-C)алкоксикарбонил, формулу (1) или (C-C)алкил, необязательно замещенный на гетероцикл; г) (C-C)алкилсульфонил; Rпредставляет собой два атома водорода или группу =0, если === представляет собой простую связь или если === представляет собой двойную связь, то Rпредставляет собой водород, циано, (C-C)алкоксикарбонил, амидо, необязательно замещенный арил или гетероцикл, (C-C)алкил, (C-C)алкенил или (C-C)алкинил, необязательно разветвленный и/или замещенный на арил или гетероцикл; арилокси, гетероциклилокси, арил-(C-C)-алкокси, гетероциклил-(C-C)алкокси, амино, замещенный на одну или две (C-C)алкильные группы, ариламино, гетероциклиламино, арил-(C-C)алкиламино, гетероциклил-(C-C)алкиламино; Rпредставляет собой
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT98MI001670A ITMI981670A1 (it) | 1998-07-21 | 1998-07-21 | Derivati ftalazinici inibitori della fosfodiesterasi 4 |
PCT/EP1999/004904 WO2000005218A1 (en) | 1998-07-21 | 1999-07-13 | Phthalazine derivatives phosphodiesterase 4 inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200100062A1 true EA200100062A1 (ru) | 2001-08-27 |
Family
ID=11380474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200100062A EA200100062A1 (ru) | 1998-07-21 | 1999-07-13 | Фталазиновые производные ингибиторов производных фосфодиэстеразы 4 |
Country Status (35)
Country | Link |
---|---|
US (2) | US6329370B1 (ru) |
EP (2) | EP1097142B1 (ru) |
JP (1) | JP2002521370A (ru) |
KR (1) | KR20010087161A (ru) |
CN (1) | CN1127486C (ru) |
AP (1) | AP2000001993A0 (ru) |
AR (1) | AR019409A1 (ru) |
AT (1) | ATE279397T1 (ru) |
AU (1) | AU765457B2 (ru) |
BG (1) | BG105063A (ru) |
BR (1) | BR9911175A (ru) |
CA (1) | CA2338044A1 (ru) |
CO (1) | CO5090842A1 (ru) |
DE (1) | DE69921139T2 (ru) |
EA (1) | EA200100062A1 (ru) |
EE (1) | EE200100039A (ru) |
HK (1) | HK1039124B (ru) |
HR (1) | HRP20010057A2 (ru) |
HU (1) | HUP0102646A3 (ru) |
ID (1) | ID28874A (ru) |
IL (1) | IL139490A0 (ru) |
IS (1) | IS5772A (ru) |
IT (1) | ITMI981670A1 (ru) |
MX (1) | MXPA01000670A (ru) |
NO (1) | NO318988B1 (ru) |
NZ (1) | NZ507926A (ru) |
OA (1) | OA11582A (ru) |
PA (1) | PA8478301A1 (ru) |
PE (1) | PE20000755A1 (ru) |
PL (1) | PL345187A1 (ru) |
SK (1) | SK1002001A3 (ru) |
TW (1) | TW509682B (ru) |
UA (1) | UA68383C2 (ru) |
WO (1) | WO2000005218A1 (ru) |
YU (1) | YU77500A (ru) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CO4950519A1 (es) * | 1997-02-13 | 2000-09-01 | Novartis Ag | Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion |
IT1296984B1 (it) * | 1997-12-19 | 1999-08-03 | Zambon Spa | Derivati ftalazinici inibitori della fosfodiesterasi 4 |
ITMI981671A1 (it) | 1998-07-21 | 2000-01-21 | Zambon Spa | Derivati ftalazinici inibitori della fosfodisterasi 4 |
DE19921567A1 (de) | 1999-05-11 | 2000-11-16 | Basf Ag | Verwendung von Phthalazine-Derivaten |
DE19963607B4 (de) * | 1999-12-23 | 2005-12-15 | Schering Ag | Verfahren zur Herstellung von 4-(Heteroaryl-methyl) halogen-1(2H)-phthalazinonen |
ITMI20000261A1 (it) | 2000-02-16 | 2001-08-16 | Zambon Group | Processo per la preparazione di piridiniliden-ftalidi |
EP1274689A2 (en) * | 2000-04-13 | 2003-01-15 | Annovis, Inc. | Sulfur containing dihydrophthalazine antagonists of excitatory amino acid receptors |
US6525049B2 (en) * | 2000-07-05 | 2003-02-25 | Pharmacia & Upjohn Company | Pyrroloquinolones as antiviral agents |
WO2002044157A2 (en) * | 2000-12-01 | 2002-06-06 | Iconix Pharmaceuticals, Inc. | Parb inhibitors |
ITMI20022738A1 (it) * | 2002-12-23 | 2004-06-24 | Zambon Spa | Derivati ftalazinici inibitori della fosfodiesterasi 4. |
ITMI20022739A1 (it) * | 2002-12-23 | 2004-06-24 | Zambon Spa | Derivati ftalazinici inibitori della fosfodiesterasi 4. |
US7652036B2 (en) | 2003-02-25 | 2010-01-26 | Topotarget Uk Limited | Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors |
ITMI20031451A1 (it) * | 2003-07-16 | 2005-01-17 | Zambon Spa | Derivati diidro-ftalazinici inibitori della fosfodiesterasi 4 |
EP1745039A4 (en) * | 2004-05-08 | 2009-07-22 | Neurogen Corp | 3-ARYL-5,6-DISUBSTITUTED PYRIDAZINES |
CA2593005A1 (en) * | 2005-01-03 | 2006-07-13 | Myriad Genetics Inc. | Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereof |
CA2626612A1 (en) | 2005-10-19 | 2007-04-26 | Ranbaxy Laboratories Limited | Pharmaceutical compositions of muscarinic receptor antagonists |
EP2131656A4 (en) | 2006-11-15 | 2011-12-07 | Forest Lab Holdings Ltd | phthalazine |
US8969348B2 (en) | 2008-08-13 | 2015-03-03 | Boehringer Ingelheim International Gmbh | Chymase inhibitors |
CN102108078B (zh) * | 2009-12-24 | 2013-10-30 | 沈阳药科大学 | 1,4-取代酞嗪类化合物及其制备方法和用途 |
KR20140090665A (ko) * | 2011-11-09 | 2014-07-17 | 아비에 도이치란트 게엠베하 운트 콤파니 카게 | 포스포디에스테라제 타입 10a의 억제제로서 유용한 헤테로사이클릭 카복스아미드 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2063249A (en) * | 1979-10-09 | 1981-06-03 | Mitsubishi Yuka Pharma | 4-Phenylphthalazine derivatives |
JPH03106873A (ja) * | 1989-09-20 | 1991-05-07 | Morishita Pharmaceut Co Ltd | 1―ピリジルフタラジン誘導体及びそれらを含有する血小板凝集抑制剤 |
ES2068413T3 (es) * | 1990-03-30 | 1995-04-16 | Mitsubishi Chem Ind | Derivados de 4-fenilftalazina. |
EP0634404A1 (en) | 1993-07-13 | 1995-01-18 | Rhone Poulenc Agriculture Ltd. | Phtalazin derivatives and their use as pesticides |
ES2224130T3 (es) * | 1994-08-09 | 2005-03-01 | Eisai Co., Ltd. | Compuesto de piridazina condensada. |
IT1296984B1 (it) * | 1997-12-19 | 1999-08-03 | Zambon Spa | Derivati ftalazinici inibitori della fosfodiesterasi 4 |
-
1998
- 1998-07-21 IT IT98MI001670A patent/ITMI981670A1/it unknown
-
1999
- 1999-07-08 PE PE1999000670A patent/PE20000755A1/es not_active Application Discontinuation
- 1999-07-13 PL PL99345187A patent/PL345187A1/xx not_active Application Discontinuation
- 1999-07-13 NZ NZ507926A patent/NZ507926A/xx unknown
- 1999-07-13 EP EP99938229A patent/EP1097142B1/en not_active Expired - Lifetime
- 1999-07-13 EP EP03102377A patent/EP1371648A1/en not_active Withdrawn
- 1999-07-13 US US09/743,813 patent/US6329370B1/en not_active Expired - Fee Related
- 1999-07-13 JP JP2000561174A patent/JP2002521370A/ja active Pending
- 1999-07-13 WO PCT/EP1999/004904 patent/WO2000005218A1/en not_active Application Discontinuation
- 1999-07-13 AP APAP/P/2000/001993A patent/AP2000001993A0/en unknown
- 1999-07-13 AT AT99938229T patent/ATE279397T1/de not_active IP Right Cessation
- 1999-07-13 EA EA200100062A patent/EA200100062A1/ru unknown
- 1999-07-13 KR KR1020017000971A patent/KR20010087161A/ko not_active Application Discontinuation
- 1999-07-13 EE EEP200100039A patent/EE200100039A/xx unknown
- 1999-07-13 IL IL13949099A patent/IL139490A0/xx not_active IP Right Cessation
- 1999-07-13 HU HU0102646A patent/HUP0102646A3/hu unknown
- 1999-07-13 AU AU52810/99A patent/AU765457B2/en not_active Ceased
- 1999-07-13 YU YU77500A patent/YU77500A/sh unknown
- 1999-07-13 DE DE69921139T patent/DE69921139T2/de not_active Expired - Fee Related
- 1999-07-13 BR BR9911175-6A patent/BR9911175A/pt not_active IP Right Cessation
- 1999-07-13 MX MXPA01000670A patent/MXPA01000670A/es not_active Application Discontinuation
- 1999-07-13 UA UA2001010439A patent/UA68383C2/uk unknown
- 1999-07-13 CA CA002338044A patent/CA2338044A1/en not_active Abandoned
- 1999-07-13 SK SK100-2001A patent/SK1002001A3/sk unknown
- 1999-07-13 ID IDW20010132A patent/ID28874A/id unknown
- 1999-07-13 OA OA1200100019A patent/OA11582A/en unknown
- 1999-07-13 CN CN99807294A patent/CN1127486C/zh not_active Expired - Fee Related
- 1999-07-16 AR ARP990103501A patent/AR019409A1/es unknown
- 1999-07-19 PA PA19998478301A patent/PA8478301A1/es unknown
- 1999-07-19 TW TW088112218A patent/TW509682B/zh not_active IP Right Cessation
- 1999-07-19 CO CO99045518A patent/CO5090842A1/es unknown
-
2000
- 2000-12-15 IS IS5772A patent/IS5772A/is unknown
- 2000-12-18 BG BG105063A patent/BG105063A/xx unknown
-
2001
- 2001-01-19 NO NO20010331A patent/NO318988B1/no not_active IP Right Cessation
- 2001-01-22 HR HR20010057A patent/HRP20010057A2/hr not_active Application Discontinuation
- 2001-10-15 US US09/976,436 patent/US6492360B1/en not_active Expired - Fee Related
-
2002
- 2002-01-25 HK HK02100584.0A patent/HK1039124B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200100062A1 (ru) | Фталазиновые производные ингибиторов производных фосфодиэстеразы 4 | |
EA200100061A1 (ru) | Производные фталазина в качестве ингибиторов фосфодиэстеразы 4 | |
EA200200299A1 (ru) | НОВЫЕ α-АМИНОКИСЛОТНЫЕ СУЛЬФОНИЛЬНЫЕ СОЕДИНЕНИЯ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ ИХ СОДЕРЖАЩИЕ | |
CY1106534T1 (el) | Αρωματικες εξαμελεις κυκλικες ενωσεις που περιεχουν αζωτο | |
UA41247C2 (ru) | Производные n-фенилпиразола | |
CO5630036A2 (es) | Nuevos derivados indol con afinidad por el receptor 5-ht6 | |
ES2191356T3 (es) | Compuestos heterociclicos para la inhibicion de la secrecion de acidos gastricos, procedimientos para su preparacion y composiciones farmaceuticas de ellos. | |
EA199900866A1 (ru) | Пиразолопиримидиноны, которые ингибируют циклический гуанозин-3',5'-монофосфат-фосфодиэстеразу типа 5 (cgmp pde5), для лечения сексуального расстройства | |
ATE409189T1 (de) | Farnesyl transferase-hemmende 6- heterocyclylmethyl-chinolin und chinazol-derivate | |
EA199900687A1 (ru) | Соединения пиразина | |
CY1106132T1 (el) | Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου | |
TR199801707T2 (xx) | PPAR-gama kar��s�nda agonist aktivite g�steren ikameli 4-hidroksi-fenilalkanoik asit t�revleri. | |
TR200003598T2 (tr) | Amid türevleri ve nosiseptin antagonistleri | |
NZ512658A (en) | Heterocyclic-substituted diphenylurea derivatives and pharmaceutical compositions containing them | |
CO5080735A1 (es) | Agonistas de prostaglandinas | |
HUP0302770A2 (hu) | Tripeptidil peptidáz inhibitorok, eljárás az előállítására és ezeket tartalmazó gyógyszerkészítmények | |
DE69630160D1 (de) | Selektive Thrombin-Hemmer | |
DK0492369T3 (da) | Hidtil ukendte tricycliske amino- og nitro-forbindelser med ACE-hæmmende virkning | |
TR200001463T2 (tr) | P maddesi antagonistleri olarak, piperidinilaminometil-triflorometil-siklik eter bileşikleri | |
DE69919192D1 (de) | Trizyklische phthalazin-derivate als phosphodiesterase 4 inhibitoren | |
CO5050264A1 (es) | Derivados de 6-azauracilo como inhibidores il-5 procedimientos para su preparacion y composiciones farmaceuticas que comprenden dichos derivados | |
BR9916314A (pt) | Inibidores tricìclicos da proteìna farnesil transferase | |
ES2055651A1 (es) | Procedimiento para la obtencion de nuevas amidinas derivadas de 3-aminoetilindoles. | |
DE69824722D1 (de) | Benzimidazole derivate | |
ECSP993061A (es) | Derivados ftalacinicos inhibidores de la fosfodiesterasa 4 |